Candesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count...
FDA Recall #D-0049-2021 — Class III — October 2, 2020
Product Description
Candesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDC 0378-3002-77) and b) 500-count bottles (NDC 0378-3002-05), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Reason for Recall
Out-of-specification organic impurity results obtained during routine stability testing.
Recalling Firm
Mylan Pharmaceuticals Inc. — Morgantown, WV
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
10,695 bottles
Distribution
Nationwide within the United States
Code Information
Lot #: a) 8095666, Exp. Date July 2021 b) 3104664, Exp. Date July 2021
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.